What are the alternative treatment options for relapsed or elderly AML patients?
ICML 2017 Highlights
Transferring lessons learnt from treating ALL to AML
Predict response to immune checkpoint inhibition in acute myeloid leukemia (AML) using biomarkers
Naval G. Daver
Moving towards personalized therapy for AML